Envoy Medical, Inc. (COCHW)
USD 0.06
(39.04%)
USD 0.06
(39.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 316 Thousand | 237 Thousand | 310 Thousand | - |
| Cost of Revenue | 789 Thousand | 957 Thousand | 769 Thousand | - |
| Gross Profit | -473 Thousand | -720 Thousand | -459 Thousand | - |
| Operating Expenses | 17.89 Million | 7.98 Million | 6.41 Million | 701.00 |
| Selling, General and Administrative Expenses | 8.94 Million | 3.47 Million | 2.47 Million | 701.00 |
| Research and Development Expenses | 8.95 Million | 4.51 Million | 3.93 Million | - |
| Other Expenses | - | -7.21 Million | -1.8 Million | - |
| Cost and Expenses | 18.68 Million | 8.94 Million | 7.18 Million | 701.00 |
| Operating Income | -18.37 Million | -8.7 Million | -6.87 Million | -700.00 |
| Interest Expense | - | - | - | - |
| Income Tax Expense | - | -153.48 Thousand | -165.55 Thousand | -206.29 Thousand |
| Earnings before Tax | -29.9 Million | -15.92 Million | -8.67 Million | -701.00 |
| Net Income | -29.9 Million | -15.92 Million | -8.67 Million | -701.00 |
| Earnings Per Share Basic | -2.38 | -1.57 | -0.85 | - |
| Earnings Per Share Diluted | -2.38 | -1.57 | -0.85 | - |
| Weighted Average Shares Outstanding | 12.55 Million | 10.15 Million | 10.15 Million | 60.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.55 Million | 10.15 Million | 10.15 Million | 60.37 Million |
| Gross Margin | -1.50 | -3.04 | -1.48 | - |
| EBIT Margin | -57.72 | -36.42 | -21.94 | - |
| Profit Margin | -94.65 | -67.19 | -27.98 | - |
| EBITDA | -18.23 Million | -8.63 Million | -6.8 Million | -700.00 |
| Earnings Before Tax Margin | -58.14 | -36.73 | -22.16 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 68 Thousand | 59 Thousand | 316 Thousand | 95 Thousand | 80 Thousand | 63 Thousand |
| Cost of Revenue | 245 Thousand | 153 Thousand | 922 Thousand | 282 Thousand | 189 Thousand | 333 Thousand |
| Gross Profit | -177 Thousand | -94 Thousand | -606 Thousand | -187 Thousand | -109 Thousand | -270 Thousand |
| Operating Expenses | 4.68 Million | 4.8 Million | 17.76 Million | 6.54 Million | 3.27 Million | 4.21 Million |
| Selling, General and Administrative Expenses | 2.09 Million | 2.44 Million | - | 3.49 Million | 1.42 Million | 2.22 Million |
| Research and Development Expenses | 2.59 Million | 2.36 Million | - | 3.05 Million | 1.85 Million | 1.98 Million |
| Other Expenses | - | - | - | - | 4.94 Million | -8.76 Million |
| Cost and Expenses | 4.92 Million | 4.95 Million | 18.68 Million | 6.83 Million | 3.46 Million | 4.54 Million |
| Operating Income | -4.86 Million | -4.89 Million | -18.37 Million | -6.73 Million | -3.38 Million | -4.48 Million |
| Interest Expense | 132 Thousand | 36 Thousand | - | - | - | - |
| Income Tax Expense | - | -9276.00 | - | - | -29 Thousand | 121.24 Thousand |
| Earnings before Tax | -3.94 Million | -6.27 Million | -29.9 Million | -4.88 Million | 1.56 Million | -13.24 Million |
| Net Income | -3.94 Million | -6.27 Million | -29.9 Million | -4.88 Million | 1.56 Million | -13.24 Million |
| Earnings Per Share Basic | -0.20 | -0.32 | - | -0.25 | 0.07 | -0.68 |
| Earnings Per Share Diluted | -0.20 | -0.32 | - | -0.25 | 0.07 | -0.68 |
| Weighted Average Shares Outstanding | 19.59 Million | 19.59 Million | 12.55 Million | 19.59 Million | 19.54 Million | 19.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.59 Million | 19.59 Million | 12.55 Million | 19.59 Million | 19.54 Million | 19.54 Million |
| Gross Margin | -2.60 | -1.59 | -1.92 | -1.97 | -1.36 | -4.29 |
| EBIT Margin | -70.85 | -82.44 | - | -70.39 | -42.31 | -71.11 |
| Profit Margin | -58.04 | -106.27 | -94.65 | -51.38 | 19.54 | -210.25 |
| EBITDA | -4.81 Million | -4.86 Million | - | -6.68 Million | -3.38 Million | -4.48 Million |
| Earnings Before Tax Margin | -71.47 | -83.02 | -58.14 | -70.89 | -42.31 | -71.11 |
4394
BONZUN
TRS
1665
WBTNF
RAMASIGNS